420
Participants
Start Date
March 31, 2005
Primary Completion Date
March 31, 2008
Study Completion Date
March 31, 2008
cytarabine
Given IV
laromustine
Given IV
placebo
Given IV
Cliniques Universitaires Saint-Luc, Brussels
CHU Charleroi - Site Vesale, Montigny-le-Tilleul
New York Medical College, Valhalla
Evaggelismos Hospital, Athens
Clinical Centre of Serbia, Belgrade
Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes, Marseille
Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital, Pittsburgh
Clinical Centre Nis, Niš
Clinic Centre Novi Sad, Novi Sad
Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore
Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz, Besançon
Duke Comprehensive Cancer Center, Durham
Brody School of Medicine at East Carolina University, Greenville
Hollings Cancer Center at Medical University of South Carolina, Charleston
University of Miami Sylvester Comprehensive Cancer Center, Miami
Hopital Haut Leveque, Pessac
Veterans Affairs Medical Center - Tampa (Haley), Tampa
CHR Hotel Dieu, Nantes
American Health Network - North Meridian, Indianapolis
Hopital Edouard Herriot, Lyon
New Mexico Cancer Care Alliance, Albuquerque
Nevada Cancer Institute, Las Vegas
Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center, Orange
UCSF Comprehensive Cancer Center, San Francisco
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center, Hartford
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago
University of Chicago Cancer Research Center, Chicago
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston
Roswell Park Cancer Institute, Buffalo
Riverside Methodist Hospital Cancer Care, Columbus
Penn State Cancer Institute at Milton S. Hershey Medical Center, Hershey
Vanderbilt-Ingram Cancer Center, Nashville
M.D. Anderson Cancer Center at University of Texas, Houston
U.Z. Gasthuisberg, Leuven
Vancouver Hospital and Health Science Center, Vancouver
Saint John Regional Hospital, Saint John
Memorial University of Newfoundland, St. John's
Capital District Health Authority Center for Clinical Research, Halifax
Ottawa Hospital Regional Cancer Centre - General Campus, Ottawa
Princess Margaret Hospital, Toronto
Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin
Medizinische Universitaetsklinik I at the University of Cologne, Cologne
Universitaetsfrauenklinik Frankfurt, Frankfurt
Universitatsklinikum Heidelberg, Heidelberg
Klinikum der Universitaet Muenchen - Grosshadern Campus, Munich
Medizinische Klinik und Poliklinik A - Universitaetsklinikum Muenster, Münster
University Wurzburg, Würzburg
University of Patras Medical School, Rio Patras
University Medical Center Groningen, Groningen
Medical University of Gdansk, Gdansk
Medical University of Lodz, Lodz
Centrum Onkologii Ziemi Lubelskiez, Lublin
Wojskowy Instytut Medyczny, Warsaw
Institute of Haematology and Blood Transfusion, Warsaw
Birmingham Heartlands Hospital, Birmingham
Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust, Cambridge
Leicester Royal Infirmary, Leicester
King's College Hospital, London
Manchester Royal Infirmary, Manchester
University Hospital of Wales, Cardiff
Lead Sponsor
Vion Pharmaceuticals
INDUSTRY